Tactile Systems

Tactile Systems Technology, Inc. is a medical technology company. It develops and provides innovative medical devices for the treatment of chronic diseases at home. The firm focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.

Earnings data Q3 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Investors need to pay close attention to Tactile Systems (TCMD) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Tactile Systems (TCMD) Stock?

MINNEAPOLIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences:

Tactile Medical to Participate in Two Upcoming Conferences in September

MINNEAPOLIS, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the 2023 Wells Fargo Healthcare Conference, which is being held at the Encore Boston Harbor in Boston, MA from September 6th - 8th. Management will participate in a fireside chat on Thursday, September 7th at 8:45 a.m. Eastern Time.

Tactile Medical to Present at the 2023 Wells Fargo Healthcare Conference

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Daniel Reuvers - President & Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Simran Kaur - Piper Sandler Margaret Kaczor - William Blair & Company Suraj Kalia - Oppenheimer & Co. Inc. Operator Welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2023 Earnings Conference Call for Tactile Medical. [Operator Instructions] Please note that this conference call is being recorded and will be available on the company's website for replay shortly.

Tactile Systems Technology, Inc. (TCMD) Q2 2023 Earnings Call Transcript

Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.14 per share a year ago.

Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Beat Estimates

MINNEAPOLIS, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2023.

Tactile Systems Technology, Inc. Reports Second Quarter 2023 Financial Results; Updates Full Year 2023 Outlook

MINNEAPOLIS, July 18, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Sherri Ferstler to the position of Senior Vice President of Sales, effective July 31, 2023. Ms. Ferstler will succeed Eric Pauls, who will be resigning from the Company, effective July 28, 2023.

Tactile Medical Appoints Sherri Ferstler as Senior Vice President of Sales

MINNEAPOLIS, June 29, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August 7.

Tactile Medical to Release Second Quarter of Fiscal Year 2023 Financial Results on August 7, 2023

Tactile Systems has outstripped peers with a tremendous rally starting in November last year. The market has no doubt increased its expectations for the company given the higher market valuation.

Tactile Systems: Lymphedema, AffloVest Markets Continue Adding Value

MINNEAPOLIS, May 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 43rd Annual Growth Stock Conference, which is being held at the Loews Chicago Hotel in Chicago, IL from June 6th – 8th. Management will host a presentation with investors on Tuesday, June 6th at 8:00 a.m. Central Time.

Tactile Medical to Present at the William Blair 43rd Annual Growth Stock Conference

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Daniel Reuvers - President and Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Simran Kaur - Piper Sandler Margaret Kaczor - William Blair & Company Ryan Zimmerman - BTIG Suraj Kalia - Oppenheimer & Co. Inc. Operator Welcome, ladies and gentlemen, to the First Quarter of Fiscal Year 2023 Earnings Conference Call for Tactile Medical. At this time, all participants have been placed in a listen-only mode.

Tactile Systems Technology, Inc. (TCMD) Q1 2023 Earnings Call Transcript

Tactile Systems Technology (TCMD) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.42 per share a year ago.

Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates

MINNEAPOLIS, May 08, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2023. First Quarter 2023 Summary: Total revenue increased 23% year-over-year to $58.8 million Lymphedema products revenue increased 22% year-over-year Airway clearance products revenue increased 24% year-over-year Operating loss of $3.8 million versus $14.9 million in Q1 2022 Non-GAAP operating loss of $2.2 million versus $5.4 million in Q1 2022 Net loss of $1.9 million versus $15.6 million in Q1 2022 Adjusted EBITDA of $0.5 million versus a $2.6 million loss in Q1 2022 First Quarter 2023 Highlights: Raised $34.6 million of net proceeds via an underwritten public equity offering Launched Entre® Plus, a next-generation version of the Entre system with enhanced features Appointed Carmen Volkart to the Company's Board of Directors Appointed Elaine Birkemeyer to the position of Chief Financial Officer “We were delighted to achieve revenue growth of over 20% in both our product lines, as our sales teams grew increasingly productive.

Tactile Systems Technology, Inc. Reports First Quarter 2023 Financial Results; Raises Full Year 2023 Outlook

The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that Tactile Systems Technology (NASDAQ: TCMD ) stock will gain 5.6% by May 30. An-E (pronounced Annie) has made this kind of prediction before.

Artificial Intelligence Engine Predicts TCMD Stock to Gain 5.6% by May 30

Apple

Boeing

BuildABear

Celsius Holdings

Cisco Systems

Enphase Energy

Intel

McDonald's

Merck

Microsoft

Northern Oil and Gas

Procter & Gamble

Direxion Daily Utilities Bull 3X Shares

Walmart

Two new Breakout Stocks for Week 15 with better than 10% short-term upside, ETF updates and a Dow 30 Picks. Average cumulative returns for 2023 are +48.5% YTD. Last week peak stock gains were in ATEX +11.62% continuing the streak of 10% gainers. Active ETF portfolio continues up +17.4% YTD.

April MDA Breakout Stocks/ETFs Week 15 - 2023: High-Frequency Gainers To Give You An Edge

MINNEAPOLIS, March 30, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2023 financial results will be released after the market opens on Monday, May 8.

Tactile Medical to Release First Quarter of Fiscal Year 2023 Financial Results on May 8, 2023

MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring.

Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer

MINNEAPOLIS, March 02, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences:

Tactile Medical to Present at Two Upcoming Conferences in March

MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $13.00 per share. The gross proceeds to Tactile Medical from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be $32.5 million. Additionally, Tactile Medical has granted the underwriter a 30-day option to purchase up to an additional 375,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. Tactile Medical anticipates using the net proceeds from the offering to (i) expand commercial activities, (ii) fund milestone payments, (iii) support new product development, (iv) broaden reimbursement coverage for Tactile Medical's patient population, (v) fund potential acquisitions and (vi) provide working capital and for other general corporate purposes, which may include general debt reduction. All of the shares are being offered by Tactile Medical, and the offering is expected to close on or about February 28, 2023, subject to customary closing conditions.

Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock

MINNEAPOLIS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Tactile Medical intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock to be sold in the proposed offering will be sold by Tactile Medical. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual terms of the offering.

Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock

Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q4 2022 Earnings Conference Call February 21, 2023 8:00 AM ET Company Participants Daniel Reuvers - President and Chief Executive Officer Brent Moen - Chief Financial Officer Conference Call Participants Adam Maeder - Piper Sandler Margaret Kaczor - William Blair Ryan Zimmerman - BTIG Suraj Kalia - Oppenheimer Operator Welcome, ladies and gentlemen to the Fourth Quarter and Fiscal Year 2022 Earnings Conference Call for Tactile Medical. At this time, all participants have been placed in a listen-only mode.

Tactile Systems Technology, Inc. (TCMD) Q4 2022 Earnings Call Transcript

Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 107.14% and 4.82%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Tactile Systems Technology (TCMD) Q4 Earnings and Revenues Top Estimates

Fourth Quarter Revenue Increased 20% Year-Over-Year; Full Year Revenue Increased 19% Year-Over-Year Fourth Quarter Revenue Increased 20% Year-Over-Year; Full Year Revenue Increased 19% Year-Over-Year

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Outlook

MINNEAPOLIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that Brent Moen has communicated his intention to retire as Chief Financial Officer in 2023.

Tactile Systems Technology, Inc. Announces Chief Financial Officer to Retire in 2023

MINNEAPOLIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2022 financial results will be released before the market opens on Tuesday, February 21st.

News for Tactile Systems Stock (TCMD)